Peginterferon α-2b as a Maintenance Therapy in Participants With Multiple Myeloma Who Responded to Induction Therapy (P01972-AM7)
Clinical trial NCT00732641 · COMPLETED
Trial details
- NCT number
- NCT00732641
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2000-12-01
- Primary completion
- 2010-11-01
- Enrollment
- 244
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.